Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeremy Gale
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects With Overt Diabetic Nephropathy
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Related publications
Association Between Pro12Ala Polymorphism and Albuminuria in Type‐2 Diabetic Nephropathy
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Interleukin-17a Blockade Reduces Albuminuria and Kidney Injury in an Accelerated Model of Diabetic Nephropathy
Kidney International
Nephrology
Association Between Serum Bilirubin and Albuminuria in Type 2 Diabetes Mellitus and Diabetic Nephropathy
International Journal of Clinical Biochemistry and Research
Urinary Biomarkers for Early Diabetic Nephropathy: Beyond Albuminuria
Pediatric Nephrology
Child Health
Pediatrics
Perinatology
Nephrology
Aliskiren in Combination With Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients With Type 2 Diabetes and Nephropathy
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy
Kidney International Reports
Nephrology
Inhibition of RAS in Diabetic Nephropathy
International Journal of Nephrology and Renovascular Disease
Nephrology
Inhibition of Type-5 Phosphodiesterase: Promising Therapy for Pulmonary Hypertension
Internal Medicine
Internal Medicine
Medicine